Background
==========

Mitochondrial heterogeneity after cytochrome oxidase staining has often been visualized in muscle \[[@B1]-[@B15]\]. Whether this is caused by varying proportions of mutant and/or depleted versus wildtype mtDNA, has not (completely) been elucidated. Müller-Höcker \[[@B16]\] using COX histochemistry demonstrated a mosaic in the liver of an infant with encephalopathy, cholestatic giant cell hepatitis and mtDNA depletion of unknown origin.

Pearson syndrome (PS) (moderate psychomotor retardation, pancytopenia and pancreatic insufficiency; MIM 557000) and Alpers-Huttenlocher syndrome (AHS) (myoclonal epilepsy, liver and brain disease; MIM 203700) are known to harbour defects of mitochondrial function \[[@B17]-[@B19]\], but mitochondrial mosaics in the liver have not been described.

We report on a 2.5 year old girl with PS, a 1-year old boy with AHS, and a 3-year old girl with mtDNA depletion; all show mosaics in their liver parenchyma. In contrast non-parenchymal cells appear microscopically normal.

Partial results were published in abstract form \[[@B20]\].

Methods
=======

Muscle stains included Gomori-trichrome, fiber typing by ATP-ase after preincubation at pH 4.6, and localisation of COX-and NADH-TR activities according to standard recipes \[[@B21]\]. In the liver cytochrome oxidase activity was visualized with diaminobenzidine according to Seligman et al \[[@B22]\], as modified by Novikoff & Goldfischer \[[@B23]\]. Briefly, liver samples were prefixed in 1% cold buffered glutaraldehyde for 2 hrs in order to preserve ultrastructure. After rinsing, cryostat sections were incubated in open vials at 37° in a DAB medium at pH 6 in acetate buffer containing 0.005 M MnCl~2~, with and without added cytochrome c (1 mg/10 ml) for 2 and 4 hrs. DAB staining of mitochondria was shown to be both O~2~and cytochrome c dependent \[[@B24],[@B25]\]. For light microscopy (LM) 7 μm sections were mounted in aquamount; for electron microscopy 60 μm sections were postfixed in 1% OsO~4~. Semithin sections were also examined by LM.

Enzymes and metabolites of oxidative phosphorylation were measured in liver, cultured fibroblasts, lymphocytes or muscle.

Blue native PAGE was performed on liver or muscle homogenate as described \[[@B26]\]. MtDNA was analysed by RT-PCR in muscle or leucocytes or liver according to \[[@B27]\]The nuclear gene *POLG*encoding polymerase gamma was sequenced as described \[[@B28]\].

For immunocytochemistry cytospins of cultured fibroblasts were prepared and stained as described \[[@B29]\]. Of liver tissue 8 μm paraffin sections were deparaffinized in xylene and rehydrated in ethanol solutions. After blocking with 2.5% BSA in PBS for 30 min, sections were incubated with primary antibodies in the same solution during 2 hours at room temperature. For the detection of each of the five complexes of the oxidative phosphorylation, monoclonal antibodies were selected that were directed against the gene products of NDUFS7, SDHB, UQCRC2, MTCO1 and ATP5A1 (Invitrogen). Immunodetection was accomplished with the alkaline phosphatase labelled EnVision polymer (Dako) and fast red chromogen. Nuclei were counterstained with hematoxylin and slides were mounted with aquatex.

Ethical issues: all tests and investigations reported in this paper were carried out for diagnostic purposes in the interest of the patients, and under the authority of the university hospitals involved. In particular the parents gave approval for the muscle and liver biopsies, as well as for publication.

Results
=======

Patients
--------

Patient 1, the daughter of non-consanguineous parents, presents with slight pancytopenia (hemoglobin 9 g/dL, leucocytes 3--5000/ml) and exocrine pancreatic dysfunction (lipase up to 700 U/L but amylase normal). In addition there is moderate psychomotor retardation; at 3 y she is not walking, and talks little. A diagnosis of Pearson syndrome is proposed. MRI shows bilateral cavities in the frontal white matter and right occipital lobe (figures [1a, b, c, d](#F1){ref-type="fig"}) and absence of the lactate spectrum. Muscle and liver biopsies are performed at 2.5 y. She dies when 3 y 3 m old.

![**Patient 1, brain MRI**. 1a: TRACE sequence shows cytotoxic oedema in frontoparietal white matter bilaterally, and in right occipital. 1b: FLAIR sequence, right occipital and bilateral frontoparietal lesions; compare to fig 1a. 1c: 5 months later. T1 weighted without iv contrast. Bifrontal white matter loss with lacunae, small lacuna in right occipital. 1d: Coronal section; bilateral loss of white matter; lacunae lined by high signal interpreted as gliosis.](1472-6890-9-4-1){#F1}

Patient 2 is the son of unrelated parents. His uncle suffered from temporal epilepsy. He presents with focal myoclonal epilepsy, axial hypotonia and moderately elevated liver enzymes in the serum (AST 150, 172, 601 U/L; ALT 102, 88, 299 U/L; gGT 83, 93 IU/L). Blood lactate is high. A first MRI at the age of 11 m is normal; but when repeated 4 weeks later it shows slight diffuse cortical atrophy (figures [2a, b, c, d](#F2){ref-type="fig"}). This leads to the tentative diagnosis of Alpers-Huttenlocher. A muscle biopsy and, at 13 m, a liver biopsy are performed. He dies at 3 y 1 m of age.

![**Patient 2, brain MRI**. 2a: T2 weighted; mild tot moderate dilatation of ventricles and peripheral liquor spaces suggesting cerebral atrophy. 2b: TRACE sequence shows cytotoxic oedema in cortex of right central gyrus. 2c: 3 months later. Focal cortical atrophy of central gyrus bilaterally. 2d: 2 years later. Focal cortical atrophy of central gyrus bilaterally.](1472-6890-9-4-2){#F2}

Patient 3. Is the daughter of non-consanguineous parents and has normal birthweight. At 3.5 months severe hypoglycemia without ketosis is detected. Hypoglycemia and high blood lactate persist during a fast longer than 5 hrs; it is irresponsive to glucagon. The patient has no cardiomyopathy. Acylcarnitine, sialotransferrine, tyrosinemia, galactosemia and urine organic acids are within normal range. Palmitate and oxanoate oxidation in cultured fibroblasts is normal. Transaminases are increased, and a liver biopsy shows micronodular cirrhosis; glucose-6-phospatase activity is normal. A muscle biopsy and a second liver biopsy are taken at 18 m. MRI is normal at the age of 2 years. At 3 y 9 m, status epilepticus develops which occurs again at 4 y and is difficult to control; and again at 4 y 10 m. At 4 y 11 m there is status epilepticus with myoclonia despite general anaesthesia. She dies from bronchopulmonary infection when 5 y old. The parents agree to an autopsy. This patient is studied in more detail in (Emmanuel Scalais and Baudouin François, in preparation)

Pathology, biochemistry and molecular biology
---------------------------------------------

Mitochondrial metabolites and respiratory chain activities in muscle or fibroblasts were unremarkable in all three patients. In the liver of patients 1 and 3 complex IV activity was decreased (Additional file [1](#S1){ref-type="supplementary-material"}).

Muscles did not show ragged-red fibers; fiber types were normally distributed at random and of comparable sizes (figures [3a, b](#F3){ref-type="fig"}). COX activity showed normal chess-board distribution of dark type 1 fibers (figure [3c](#F3){ref-type="fig"}). In patient 2 COX activity seemed diminished, but this can be due to the delay between sampling and staining. Mitochondrial distribution visualized by NADH-TR was always normal (figure [3d](#F3){ref-type="fig"}).

![**Muscle pathology**. 3a: ATP-ase reaction at pH 4.6 shows regular sizes and normal chessboard distribution of 3 fiber types. Patient 2. 3b: Gomori trichrome shows normal image; absence of ragged-red fibers. Patient 1. 3c: Cytochrome oxidase activity shows normal distribution of mitochondria in distinct fiber types; compare to 3d. Patient 3. 3d: NADH-tetrazolium reductase shows normal distribution of mitochondria; compare to COX stain in 3c. Patient 1.](1472-6890-9-4-3){#F3}

Blue native PAGE of liver of patient 1 demonstrated very low complex IV (cytochrome oxidase) activity, and a slightly decreased activity in the liver of patient 3, but it was normal in muscle of patients 2 and 3. Complex V (mitochondrial ATP-ase) revealed subcomplexes in patient 1, and in both tissues of patient 3 (figure [4](#F4){ref-type="fig"}).

![**Blue native PAGE of the OXPHOS complexes**. In-gel activity staining. In patient 1 (Pearson syndrome), the activity of complex IV is severely decreased in liver. In patient 2 (POLG mutation), complex I and complex II are slightly decreased in skeletal muscle (a limited amount of muscle from the patient was available for testing and the complex II band was weak in the control as well). Normal activities are detected in mitochondria from skeletal muscle of patient 3 (POLG mutation). In liver mitochondria of this patient the activities of complex I, III and IV are slightly decreased. In mitochondria from all patients subcomplexes of complex V are seen (only weakly in patient 2), which is considered as a marker of disturbed intramitochondrial protein synthesis.](1472-6890-9-4-4){#F4}

### Liver histology

micro- and macrovesicular steatosis is seen in patients 2 and 3. In patient 2 reticulin lining of hepatocytes was thicker or double, and after CK7 immunoreaction, metaplasia of the parenchyma was detected. Both features suggest a reaction to earlier cell death. However no signs of ongoing necrosis were seen.

In the liver of patient 3 micronodular cirrhosis was obvious, and was even more severe at autopsy (figure [5a](#F5){ref-type="fig"}). Kupffer cells contained many PAS-positive granules that often were large; they stained positive for acid phosphatase. By electron microscopy as well these lysosomes were conspicuous, but their contents were not suggestive of a specific storage disorder.

![**Liver, patient 3**. 5a: micronodular cirrhosis at 18 months; trichrome stain. 5b: small group of COX reactive parenchymal cells adjacent to an unstained region. Cryostat section, cytochrome oxidase reaction, nuclei slightly counterstained with methylgreen.](1472-6890-9-4-5){#F5}

### Cytochrome oxidase localisation in liver

by LM the DAB staining reaction appeared negative in several liver sections of patients 1 and 3, however in other areas of the biopsy fragments, islets of hepatocytes were found that reacted for COX activity (figures [5b](#F5){ref-type="fig"}, [6a, b](#F6){ref-type="fig"}). In patient 2 COX stained regions alternated with weakly staining and unstained ones (figures [7a, b](#F7){ref-type="fig"}). Sometimes single hepatocytes with stained mitochondria were surrounded by unstained cells. Total area with active COX was estimated to be larger than the unstained areas in pt 2; in contrast COX positive cells were a minority in patients 1 and 3, approximately 10% in patient 3. In patients 2 and 3 bile duct epithelium and arterial smooth muscle cells revealed granular, i.e. mitochondrial staining.

![**Liver, patient 1, cytochrome oxidase stain**. 6a: low power view of cryostat section; islet of stained cells surrounded by unstained parenchyma. Large dark granules are erythrocytes in sinusoids and Kupffer cells that stain for peroxidase (arrow). Patient 1. 6b: high power of sharp border between COX stained and unstained parenchymal cells. Numerous tightly packed granules are mitochondria. In the unstained cells, the fewer small round granules are peroxisomes reacting by their catalase. Postosmicated, semithin plastic section.](1472-6890-9-4-6){#F6}

![**Liver, patient 2, cytochrome oxidase stain**. 7a: Different levels of mitochondrial staining in adjacent hepatocytes, cryostat section. Nuclei slightly counterstained with methylgreen reveal cells without staining (arrow). 7b: Higher magnification: COX-positive parenchymal cells alternate with unstained ones. Large dark structures are erythrocytes (arrow). Nuclei slightly counterstained with methylgreen, cryostat section.](1472-6890-9-4-7){#F7}

Addition of cytochrome c to the reaction medium did not result in a convincing increase of staining in either patient, indicating that endogenous cytochrome c was not rate-limiting.

By electron microscopy parenchymal cells with a strong reaction in inner mitochondrial membrane and cristae were found adjacent to cells with mitochondria without visible contrast and mitochondria with one or two cristae that reacted (figures [8](#F8){ref-type="fig"}, [9](#F9){ref-type="fig"}, [10](#F10){ref-type="fig"}, [11](#F11){ref-type="fig"}, [12](#F12){ref-type="fig"}, [13](#F13){ref-type="fig"}). The latter organelles are expected to be invisible by LM. In some of these organelles cristae appeared scarce and/or misshapen (figures [12](#F12){ref-type="fig"}, [13](#F13){ref-type="fig"}). In all 3 patients most mitochondria had too few or no cristae by ultrastructural morphology; mitochondrial number seemed to be increased (figures [8](#F8){ref-type="fig"}, [10](#F10){ref-type="fig"}) but this was not evident in all hepatocytes. In patient 3 several mitochondria showed invaginations of their envelope containing cytoplasm and glycogen rosettes (figure [13](#F13){ref-type="fig"}).

![**Liver: ultrastructure and reaction for cytochrome oxidase**. Fig 8: COX reaction product stains mitochondrial envelope and cristae. 4 parenchymal cells have different levels of mitochondrial reaction. Peroxisomes are dark round bodies (arrows), they stand out in the hepatocyte without COX reaction; here mitochondrial numbers appear increased. Patient 1.](1472-6890-9-4-8){#F8}

![**COX reaction: parenchymal cell in the center shows mitochondria devoid of reaction product**. It is surrounded by cells with well-stained mitochondria. Tiny granules are glycogen. Patient 2.](1472-6890-9-4-9){#F9}

![**COX reaction: 2 hepatocytes with well-contrasted mitochondrial envelopes and cristae**. In the third cell that contains many lipid globules, only some mitochondria have a few stained cristae (arrow); mitochondrial numbers appear increased. Patient 2.](1472-6890-9-4-10){#F10}

![**COX reaction: only single or few cristae show COX reaction product**. Large lipid globules are either dark, grey or largely dissolved. Tiny dark granules are glycogen. Patient 3.](1472-6890-9-4-11){#F11}

![**COX reaction: mitochondrion (asterisk) with only two circular cristae reacting; other mitochondria in this hepatocyte are unstained**. Adjacent cell shows strongly reacting mitochondrial envelopes and cristae; also lipid. Dark bodies are peroxisomes (arrows). Patient 1.](1472-6890-9-4-12){#F12}

![**COX reaction: Single reacting semicircular crista**. Other mitochondria are (nearly) unreactive; two show invaginations (arrow) containing glycogenrosettes and cytosol. Patient 3.](1472-6890-9-4-13){#F13}

In patients 1 and 2 the small mitochondria of bile duct epithelial cells, vascular smooth muscle, endothelial cells, Kupffer cells and neutrophils reacted strongly, adjacent to parenchyma with poorly reactive mitochondria (figures [14](#F14){ref-type="fig"}, [15](#F15){ref-type="fig"}). Also in patient 3 positive mitochondria were seen in a non-parenchymal cell.

![**COX reaction in non-parenchymal cells**. COX reaction: numerous well stained mitochondria in lining cells of a bile duct (or capillary); a basal lamina is present. Adjacent hepatic parenchyma shows dark peroxisomes while mitochondria have only a few reactive cristae. Patient 1.](1472-6890-9-4-14){#F14}

![**COX reaction: strongly reactive mitochondria in a cell identified by its microfilaments as vascular smooth muscle**. Patient 1.](1472-6890-9-4-15){#F15}

Glycogen rosettes were abundant in the parenchymal cytosol in the three livers, as is usual in well-fed infants.

Steatosis in the liver of patient 2 was considerable in both hepatocytes with well stained or unstained mitochondria. Since cells with minimal COX reaction showed no ultrastructural signs of anoxia or cell damage, such as dilated ER or swollen mitochondria, a primary mitochondrial enzyme defect is most likely.

### Immunocytochemistry of OXPHOS proteins

the livers of patients 2 and 3 displayed a mosaic staining pattern for both complexes I and IV (figure [16a](#F16){ref-type="fig"}). Immunoreactivity for complexes II, III and V was preserved in all liver cells (figure [16b](#F16){ref-type="fig"}).

![**Immunocytochemistry of OXPHOS proteins in liver of patient 3**. 16a: complex IV (coloured red) is present only in islets of cells amid unstained parenchyma. 16b: complex II is present in red granules, i.e. in mitochondria in all parenchymal cells.](1472-6890-9-4-16){#F16}

In cultured fibroblasts from patient 2, a mosaic of positive and negative cells was observed for complex I; in contrast complexes II, III, IV and V were revealed in all cells. Fibroblasts from patient 3 displayed immunostaining in all cells.

### DNA analysis

in *patient 1*(leukocytes) a \"common\" deletion of 4977 bp in 50% of the mtDNA molecules was found, in agreement with earlier cases of Pearson syndrome.*Patient 2*: muscle showed 60% depletion of the mtDNA content by real time quantitative PCR analysis, and no mutation of mtDNA, in agreement with the clinical diagnosis of Alpers-Huttenlocher syndrome. Subsequent analysis of the nuclear DNA showed a heterozygous recessive mutation in the *POLG*gene, predicting an A467T amino acid substitution \[[@B28]\] in combination with a previously unreported heterozygous recessive splice site mutation c.3643+2t\>c.

We also sequenced DNA of both parents, and the father carried the A467T mutation only, whereas the splice site mutation was present in the mother. This finding confirms that both mutations are located on different alleles and suggests that the combination of these mutations is very likely to cause the patients phenotype. Furthermore, the novel mutation alters an evolutionary conserved splice site and is located in the splice donor GT sequence, which is functionally important in the splicing process. Online tools predict that the donor site cannot be recognized as such because of this sequence alteration (e.g. <http://bioinfo.itb.cnr.it/oriel/splice-view.html>). We conclude that the c.3643+2T\>C mutation is a genuine novel pathogenic mutation in POLG.

*Patient 3*: real time PCR quantification of mtDNA showed a depletion of 74% and 74% of mtDNA contents in muscle and liver, respectively. *POLG*sequencing showed 2 heterozygous recessive mutations, predicting A467T and G848S aminoacid substitutions \[[@B28],[@B30]\].

Discussion
==========

Although mitochondrial mosaics after COX staining have been known in skeletal muscle and myocardium since 1983, only a single case has been reported in liver \[[@B16]\].

COX histochemistry can be carried out within 24 hrs and is easy to perform. In our patients it yielded evidence, already by light microscopy, of the underlying pathological mechanism, i.e. partial defects in COX activity, whereas tests in blood and muscle were normal or not helpful. The COX deficiency directed subsequent analysis towards blue native electrophoresis of the OXPHOS proteins and to mtDNA.

It is striking that COX activity in skeletal muscle cells, visualized also with DAB, had a normal pattern. Non-parenchymal cells in the liver appeared not to participate in the mosaics, which were limited to the hepatic parenchyma, an observation also made by Müller-Höcker et al \[[@B16]\]. But considering the clinical symptoms it is likely that brain cells, exocrine pancreas and bone marrow had COX deficiency as well. Mild brain atrophy on MRI and psychomotor retardation were also present in the patient of Müller-Höcker et al.

When interpreting the absence of, or very weak stain in single mitochondria at ultrastructure, it should be recalled that the tissue was prefixed in aldehyde which inhibits part of COX activity. One can speculate therefore that liver cells devoid of DAB stain, were actually not entirely without COX activity. Indeed it would be difficult for a cell without any COX to survive for long.

How can the cell- and tissue heterogeneity of the COX activity be explained?

Many disorders have been linked to heteroplasmic alterations in mtDNA: in muscle \[[@B6]\], liver \[[@B31]\], cardiomyocytes and other tissues. Clinical syndromes associated with heteroplasmy are several types of myopathy \[[@B5],[@B6]\]; myoclonus epilepsy and ragged red fibers (MERRF) \[[@B4]\]; progressive external ophtalmoplegia, childhood optic atrophy, followed by deafness and ataxia later \[[@B8]\]; dilated cardiomyopathy \[[@B32]\]; multiple lipomas \[[@B33]\]; Kearns-Sayre syndrome (MIM 530000)\[[@B34],[@B35]\]; focal segmental glomerulosclerosis \[[@B36]\]; early onset diabetes mellitus, optic atrophy and deafness (Wolfram syndrome)\[[@B37]\]; Alpers-Huttenlocher-like disease \[[@B31]\]; and Pearson syndrome with Kearns-Sayre encephalomyopathy \[[@B9]\].

The histochemical COX staining in individual muscle fibers appears to be linked to the expression of a mutation in mtDNA \[[@B4]\] and heterogeneous defects in COX activity may be due to differing populations of wildtype and mutant mtDNA (\[[@B10]\]. Hudson et al \[[@B8]\] showed that COX-positive vs. negative fibers in muscle are correlated to their level of mtDNA deletion.

In *patient 1*, the observed deletion in the mtDNA that encodes for the complex IV protein, might be limited to part of the liver parenchyma *if*this mutation was generated early during liver histogenesis in a single cell hitting only its descendants. But also blood cells bear the mutation (it was found there). There is no simple model for a common origin of both celltypes, blood cells and (part) of the hepatocytes; less so for the neurons and most glia in the brain some of which must have low COX activity.

A different mechanism proposes that the mutation intervened early in development, possibly even in the oocyte, that both mutated as well as wild-type mitochondria proliferated but were distributed at random in the daughter cells, and thus not equally in every cell. This results in varying proportions of normal and defective mitochondria per cell, so-called \"shift\", or \"drift\" of the genotype \[[@B38]\]. Larsson et al \[[@B35]\] concluded that \"the phenotype can change with time and is governed by fractional concentration in different tissues of the mtDNA with the deletion\". Chinnery et al \[[@B5]\] think it is likely that the progression in time of the COX defect in muscle \"is due to clonal expansion of mutant mtDNA\". The frequently observed sequence in Pearson syndrome of early hematopoietic dysfunction followed later by lactic acidosis, pancreas dysfunction and symptoms of Kearns-Sayre syndrome, has been tentatively explained by \"chance distribution of the deleted molecules among the tissues through redistribution\" \[[@B39]\]. COX-negative, but also ragged-red muscle fibers (absent in our case) were found in a 8-year old boy who combined the symptoms of Pearson and Kearns-Sayre syndromes \[[@B9]\]. Moreover, we speculate that cell death, ensuing each time COX activity falls below the survival threshold, will trigger compensatory hyperplasia in those tissues that are capable of regeneration, and enable an enrichment with COX-positive cells, i.e. among liver cells of all types, lymphocytes and bone marrow cells, and, in young individuals, even brain cells: glia no doubt, and perhaps even neurons. In neurons proliferative capacity quickly regresses with age; this might explain why the neonate was symptom-free but subsequently developed progressive lesions leading to death.

That cultured fibroblasts of our patients gave normal tests is not unexpected: the phenotypic expression of respiratory chain disorders is unstable in cultured cells and tends to return to normal values \[[@B38],[@B40]\]. In their recent review on disorders of mtDNA synthesis, Freisinger et al. state that fibroblasts are not suitable for assays of depletion \[[@B41]\]. A possible explanation is that cultured cells originate from mothercells that have wild-type mtDNA while the mutated cells die or do not proliferate.

A mosaic of COX activity in muscle has also been observed in a case of a homoplasmic mutation of mtDNA \[[@B14]\]; this is more difficult to explain.

On the other hand *patients 2 and 3*had a large depletion of the amount of mtDNA.

Depletion syndromes are associated with [nuclear]{.ul} mutations of *DGUOK*\[[@B42]\], *SUCLA2*, *SUCLG1*, *TK2*, *MPV17*\[[@B43]\], *PEO1*\[[@B44]\], *RRM2B*, and *POLG*; the last is the case in two of our patients. Mutations in the *POLG*gene were previously reported in AHS by three groups \[[@B17]-[@B19],[@B45]-[@B47]\] and most recently by Stewart et al. \[[@B15]\] who describe 9 patients with a COX mosaic in muscle, but none in liver.

How can one explain a mitochondrial mosaic linked to a nuclear mutation?

Comparing muscle of two patients Moraes et al \[[@B48]\] found a correlation between the degree of mtDNA depletion and COX activity. Since the reduction of mtDNA in cell cultures results in gradual loss of respiratory rate and COX activity \[[@B49]\], the question can be rephrased as follows: why is the level of depletion varying between individual mitochondria, individual cells, and tissues?

Models for tissue specificity of the expression of nuclear mutations impairing the enzymes required for mtDNA synthesis are proposed by several groups; they are based on interactions of distinct gene products required for this synthesis, enzymes as well as metabolites.

*In muscle*the dNTP transporter securing import of cytosolic deoxyribonucleotides for mtDNA synthesis, is normally low. Partial loss by a mutation of the mitochondrial enzyme thymidine kinase-2 will result in critically low levels of DNA. In contrast other celltypes where more dNTP transporter is available will be spared although the mutation is present \[[@B50]-[@B53]\].

*In brain*a mutation of succinyl-CoA synthetase-A (required for ADP synthesis) combined to a normally very low mitochondrial NDPKinase (that phosphorylates ADP) will again result in shortage of precursors and thus depletion of DNA \[[@B51]\]. Other tissues have more dNDPK.

The cytosolic deoxycytosinekinase has an overlapping substrate specificity with deoxyguanosinekinase. But in *liver and brain*it is normally very low; a mutation of deoxyguanosinekinase cannot be compensated and will result in DNA depletion limited to those tissues \[[@B52]\] or more severe than in muscle \[[@B53]\]. Vice versa, Taanman et al. have shown that supplementation of dGMP and dAMP to fibroblasts can prevent mtDNA depletion \[[@B54]\]. Hepatic and brain-specific phenotypes are known in mutations of deoxyguanosine kinase \[[@B55]\], and reversal of the phenotype was also described \[[@B56]\].

Sarzi et al. discussing two sibs with a hepatocerebral syndrome and a TWINKLE mutation, suggest that tissue specific differences of nucleotides as well as the normally higher activity of helicase in muscle compared to liver explain the organ specificity of the disease \[[@B57]\].

Galassi et al., discussing a patient with one mutation in POLG-A and a second in ANT1, mention the possibility that the complex clinical features \"may be due to cooperative effects consequent to the interrelation of two mitochondrial functions both converging on the homeostatic control of mtDNA maintenance and stability\" \[[@B58]\].

Another mechanism for variability in phenotypic expression and possibly for tissue- and cell-specific deficiency is reversal of the mutation in the *TK2*gene that caused mtDNA depletion \[[@B59]\].

When liver is compared to muscle, in 4 unrelated children with AHS, there was respiratory chain enzyme deficiency in liver, but not in muscle \[[@B60]\]. In a recent series of 10 children with mutations in *POLG1*, 5 had normal enzymes in muscle \[[@B61]\]. The authors conclude that the assay of mitochondrial enzymes in muscle alone is not effective. Mutations in *DGUOK*causing mtDNA depletion nearly always result in normal muscle enzymes, and the study of liver is recommended \[[@B41]\]. The patients with the mutation in *PEO1*had a severe reduction of OXPHOS complexes in the liver and not in muscle \[[@B57]\]. In a large series of patients with mtDNA depletion and mutations in *DGUOK, POLG*, *MPV17*or *TK2*, 17 cases had lowered respiratory enzymes in liver but normal activities in muscle \[[@B62]\].

Given the frequency of tissue heterogeneity, mitochondrial mosaics in liver may be more frequent than reported until now.

Whether mosaics after COX staining of the liver were present in these cases from the literature has not been studied.

Finally it is tempting to speculate on the relationship between clinical severity and proportions of COX deficient mitochondria in the mosaics. In patient 1 by far the smallest ratio of stained/unstained mitochondria in the liver coexisted with the severest brain lesions on MRI; on the other hand liver transaminases were unremarkable. *Hepatic*disease was more pronounced in the AH patient, as estimated by the liver enzymes AST, ALT and gGT. The 3rd patient\'s liver, with 10% of the hepatocytes with reacting mitochondria, had already developed cirrhosis at 3 months of age, but cerebral symptoms appeared only 3 years later. When taking into account the extraordinary regenerative capacity of liver parenchyma, and the near absence of such capacity in the brain, we see as yet no simple correlation between disease severity and the observed distribution of COX deficiency in the liver.

Conclusion
==========

A tentative explanation for the mitochondrial mosaics is, in patient 1, unequal partition of mutated mitochondria during mitoses, and in patients 2 and 3, an interaction between products of several genes required for mtDNA maintenance.

Histoenzymatic COX staining of a liver biopsy is fast and yields crucial data about the pathogenesis; it indicates whether mtDNA should be assayed. Each time muscle data are non-diagnostic, a liver biopsy should be recommended. Mosaics are probably more frequent than observed until now.
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